Study of Radiotherapy Combined With Cisplatin/Carboplatin, Adebrelimab and Bevacizumab in the Treatment of TNBC-BM.

NCT07638852 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

58

Enrollment

OTHER

Sponsor class

Conditions

TNBC, Triple Negative Breast Cancer
Brain Metastasases

Interventions

RADIATION: Radiation Therapy
DRUG: Adebelimab
DRUG: Bevacizumab
DRUG: Cisplatin or carboplatin

Sponsor

Fudan University